Lincoln Pharma gets Gujarat food and drug controller gesture to make HCQ tablets Kumar Jeetendra | April 27, 2020 Lincoln Pharmaceuticals hit an upper circuit breaking point of 5% at Rs 152.70 after the organization said it got endorsement to fabricate Hydroxychloroquine and Hydroxychloroquine Sulfate tablets to battle Covid-19. Lincoln Pharmaceuticals reported during exchanging hours today, 27 April 2020, that it has gotten endorsement to make Hydroxychloroquine (HCQ) among other basic medications to battle …
HIV medication may supplant HCQ in ICMR’s amended COVID-19 treatment convention: Report Kumar Jeetendra | May 19, 2020 The Indian Council of Medical Research (ICMR) is surveying its COVID-19 treatment rules. The wellbeing authority may drop hydroxychloroquine, prevalently called HCQ, from the convention because of expanding question over its viability, The Economic Times has revealed. The report recommends that ICMR is probably going to incorporate HIV blend medications and FDA-endorsed Ivermectin alongside enhancements …
